This inventor holds 2 USPTO granted patents and 1 published patent application and 1 EPO patent. Top assignees: National Institute of Health and Medical Research, Université De Lille 2 Droit Et Santé, Centre Hospitalier Regional Et Universitaire De Lille (Chru). Active years: 2018-2020.
Company Filing History:
2 out of 1,853 
2 out of 13 
1 out of 10 Years Active: 2018-2020
Title: Nicolas Le Fur: Innovator in Tauopathy Treatment
Introduction
Nicolas Le Fur is a notable inventor based in Roubaix, France. He has made significant contributions to the field of medicine, particularly in the treatment of Tauopathies. With a total of 2 patents to his name, his work is recognized for its potential impact on healthcare.
Latest Patents
Nicolas Le Fur's latest patents include a compound known as 1,4-bis(3-aminopropyl)piperazine derivative. This invention relates to the compound having Formula (I) or pharmaceutically acceptable salts or solvates thereof. It is specifically aimed at treating and/or preventing a Tauopathy. The innovative nature of this compound highlights his commitment to advancing medical science.
Career Highlights
Throughout his career, Nicolas Le Fur has worked with esteemed institutions such as the Institut National de la Santé et de la Recherche Médicale and Université de Lille 2 Droit et Santé. His experience in these organizations has allowed him to develop and refine his inventions, contributing to the medical community's understanding of Tauopathies.
Collaborations
Nicolas Le Fur has collaborated with notable colleagues, including Nicolas Sergeant and Luc Buee. These partnerships have fostered a collaborative environment that encourages innovation and the sharing of ideas.
Conclusion
Nicolas Le Fur's contributions to the field of medicine, particularly through his patents related to Tauopathy treatment, underscore his role as a significant inventor. His work continues to inspire advancements in healthcare and medical research.